A detailed history of Hartford Investment Management CO transactions in Bio Techne Corp stock. As of the latest transaction made, Hartford Investment Management CO holds 9,993 shares of TECH stock, worth $731,187. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,993
Previous 10,109 1.15%
Holding current value
$731,187
Previous $724,000 10.22%
% of portfolio
0.03%
Previous 0.03%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$70.96 - $82.35 $8,231 - $9,552
-116 Reduced 1.15%
9,993 $798,000
Q2 2024

Aug 01, 2024

SELL
$62.12 - $84.15 $4,783 - $6,479
-77 Reduced 0.76%
10,109 $724,000
Q1 2024

Apr 17, 2024

SELL
$65.98 - $77.09 $31,736 - $37,080
-481 Reduced 4.51%
10,186 $716,000
Q4 2023

Jan 23, 2024

SELL
$52.83 - $78.22 $8,928 - $13,219
-169 Reduced 1.56%
10,667 $823,000
Q3 2023

Oct 16, 2023

SELL
$67.52 - $89.42 $20,526 - $27,183
-304 Reduced 2.73%
10,836 $737,000
Q2 2023

Jul 19, 2023

SELL
$73.76 - $85.98 $163,894 - $191,047
-2,222 Reduced 16.63%
11,140 $909,000
Q1 2023

May 09, 2023

BUY
$71.62 - $86.62 $138,083 - $167,003
1,928 Added 16.86%
13,362 $991,000
Q4 2022

Jan 20, 2023

BUY
$80.67 - $352.29 $619,464 - $2.71 Million
7,679 Added 204.5%
11,434 $948,000
Q3 2022

Nov 02, 2022

SELL
$282.54 - $391.85 $5,085 - $7,053
-18 Reduced 0.48%
3,755 $1.07 Million
Q2 2022

Jul 22, 2022

BUY
$322.67 - $449.65 $12,261 - $17,086
38 Added 1.02%
3,773 $1.31 Million
Q1 2022

Apr 20, 2022

SELL
$353.85 - $487.79 $100,847 - $139,020
-285 Reduced 7.09%
3,735 $1.62 Million
Q4 2021

Feb 02, 2022

BUY
$456.15 - $525.06 $160,564 - $184,821
352 Added 9.6%
4,020 $2.08 Million
Q3 2021

Nov 01, 2021

BUY
$444.87 - $538.88 $1.63 Million - $1.98 Million
3,668 New
3,668 $1.78 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.87B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.